Annals of the New York Academy of Sciences

Role of hair follicles in the pathogenesis of arsenical-induced cutaneous damage.  1515:168-183. 2022

Circulating and tissue biomarkers as predictors of bromine gas inhalation.  1480:104-115. 2020

Halogen exposure injury in the developing lung.  1480:30-43. 2020

Protective role of HO-1 against acute kidney injury caused by cutaneous exposure to arsenicals.  1480:155-169. 2020

Cutaneous lewisite exposure causes acute lung injury.  1479:210-222. 2020

Hyaluronan and halogen-induced airway hyperresponsiveness and lung injury.  1479:29-43. 2020

MicroRNA-mediated inflammation and coagulation effects in rats exposed to an inhaled analog of sulfur mustard.  1479:148-158. 2020

New research directions on disparities in obesity and type 2 diabetes.  1461:5-24. 2020

The expanding functional roles and signaling mechanisms of adhesion g protein–coupled receptors.  1456:5-25. 2019

Learning from the past: Reflections on recently completed myasthenia gravis trials.  1412:5-13. 2018

Muscle–bone interactions: Movement in the field of mechano–humoral coupling of muscle and bone.  1402:10-17. 2017

Disease drivers of aging.  1386:45-68. 2016

Biological and environmental hazards associated with exposure to chemical warfare agents: arsenicals.  1378:143-157. 2016

Chlorine-induced cardiopulmonary injury.  1374:159-167. 2016

Emerging targets for treating sulfur mustard–induced injuries.  1374:123-131. 2016

Role of heme in bromine-induced lung injury.  1374:105-110. 2016

Significant life extension by ten percent dietary restriction.  1363:11-17. 2016

FCRL regulation in innate-like B cells.  1362:110-116. 2015

The role of evolutionarily conserved germ-line DH sequence in B-1 cell development and natural antibody production.  1362:48-56. 2015

Function and regulation of primary cilia and intraflagellar transport proteins in the skeleton.  1335:78-99. 2015

Bone safety of low-dose glucocorticoids in rheumatic diseases.  1318:55-64. 2014

Circadian clocks, brain function, and development.  1306:43-67. 2013

Biomarker development for myasthenia gravis.  1275:101-106. 2012

Conjectures on some curious connections among social status, calorie restriction, hunger, fatness, and longevity.  1264:1-12. 2012

Population shifts and the future of stroke: Forecasts of the future burden of stroke.  1268:14-20. 2012

Barrett's esophagus: Surgical treatments.  1232:175-195. 2011

Anthropogenic impacts on marine ecosystems in Antarctica.  1223:82-107. 2011

Barrett's esophagus: Endoscopic diagnosis.  1232:53-75. 2011

Chemosensitization of tumors by resveratrol.  1215:150-160. 2011

New approaches for treating staphylococcal biofilm infections.  1241:104-121. 2011

Animal models of reproductive aging: What can they tell us?.  1204:123-126. 2010

Humanized mouse models of Cooley's anemia: Correct fetal-to-adult hemoglobin switching, disease onset, and disease pathology.  1202:45-51. 2010

Role of HIF-1α in skeletal development.  1192:322-326. 2010

Organization, integration, and assembly of genetic and epigenetic regulatory machinery in nuclear microenvironments: Implications for biological control in cancer.  1155:4-14. 2009

Single molecule probing of SNARE proteins by atomic force microscopy.  1152:113-120. 2009

Genes and molecules that can potentiate or attenuate psychostimulant dependence: Relevance of data from animal models to human addiction.  1141:76-95. 2008

Rules of evidence for clinical trials: The science of finding the truth?.  1132:233-237. 2008

Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.  1132:344-347. 2008

Oxygen sensing and osteogenesis.  1117:1-11. 2007

Mitochondria damage checkpoint, aging, and cancer.  1067:182-190. 2006

Molecular approaches to the role of the microbiota in inflammatory bowel disease.  1072:39-51. 2006

NFATc1: A novel anabolic therapeutic target for osteoporosis.  1068:564-567. 2006

Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors.  1074:1-12. 2006

Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS.  1068:297-308. 2006

Effects of extracellular calcium on fASIC1 currents.  1048:331-336. 2005

Early upregulation of T cell IL-10 production plays an important role in oral tolerance induction.  1029:319-20. 2004

Early upregulation of T cell IL-10 production plays an important role in oral tolerance induction.  1029:319-320. 2004

Genome-wide analysis of signal transducers and regulators of mitochondrial dysfunction in Saccharomyces cerevisiae.  1011:284-298. 2004

Isolated lymphoid follicles can function as sites for induction of mucosal immune responses.  1029:44-57. 2004

Mitochondrial dysfunction is a common phenotype in aging and cancer.  1019:260-264. 2004

Oral tolerance in humans: Failure to suppress an existing immune response by oral antigen administration.  1029:299-309. 2004

Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration.  1029:299-309. 2004

Antibody repertoire in a mouse with a simplified DH locus: The D-limited mouse.  987:262-265. 2003

Molecular mechanism of serial VH gene replacement.  987:270-273. 2003

Mass and thermal diffusivity algorithms: Reduced algorithms for mass and thermal diffusivity determinations.  974:146-156. 2002

The influence of gravity on composition uniformity and microstructure in immiscible Al-In alloys.  974:102-109. 2002

Dysregulation of [Ca²⁺]i in OK-PTH cells expressing a mesangial cell Na⁺/Ca²⁺ exchanger isoform from Dahl/Rapp salt-sensitive rats.  976:338-341. 2002

Enhanced susceptibility of a Na⁺/Ca²⁺ exchanger isoform from mesangial cells of salt-sensitive Dahl/Rapp rats to oxidative stress inactivation.  976:342-344. 2002

Glutathione in defense and signaling: Lessons from a small thiol.  973:488-504. 2002

Identification of chronic cocaine-induced gene expression through dopamine D1 receptors by using cDNA microarrays.  965:1-9. 2002

Neural mechanisms for the control of vergence eye movements.  956:264-272. 2002

Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism.  948:51-66. 2001

Inflamm-aging. An evolutionary perspective on immunosenescence.  908:244-254. 2000

Probing the role of the dopamine D1 receptor in psychostimulant addiction.  914:13-21. 2000

Reactive species in sickle cell disease.  899:375-391. 2000

The proopiomelanocortin system in cutaneous neuroimmunomodulation. An introductory overview..  885. 1999

ACTH production in C57BL/6 mouse skin.  885:448-450. 1999

Desensitization of nicotinic receptors in the central nervous system.  868:620-623. 1999

Differential temporal and spatial expression of POMC mRNA and of the production of POMC peptides during the murine hair cycle.  885:427-429. 1999

Distribution of group III mGluRs in rat basal ganglia with subtype-specific antibodies.  868:531-534. 1999

Proopiomelanocortin and the immune-neuroendocrine connection.  885:161-172. 1999

UV light and MSH receptors.  885:100-116. 1999

Cocaine-Inhibited Neuronal Differentiation in NGF-Induced PC12 Cells and Altered C-fos Expression Are Reversed by C-fos Antisense Oligonucleotidea..  846:427-430. 1998

Cutaneous immunomodulation and coordination of skin stress responses by α-melanocyte-stimulating hormone A.  840:381-394. 1998

Bilateral integration of sensorimotor signals during pedaling.  860:513-516. 1998

Cocaine-inhibited neuronal differentiation in NGF-induced PC12 cells and altered C-fos expression are reversed by C-fos antisense oligonucleotide.  846:427-430. 1998

Effects of antimetabolites to glucose and fatty acids on galanin-1 receptor mRNA levels in the hypothalamic paraventricular and supraoptic nuclei.  863:430-431. 1998

Experimental models to study molecular mechanisms underlying intestinal disease. Proceedings of Symposium Intestinal Plasticity in Health and Disease.  859:85-95. 1998

Experimental models to study molecular mechanisms underlying intestinal inflammation.  859:85-95. 1998

RBC adhesion to cremaster endothelum in mice with abnormal hemoglobin is increased by topical endotoxin.  850:391-393. 1998

CDR3 fingerprinting of immunoglobulin kappa light chains expressed in rheumatoid arthritis. Evidence of antigenic selection or dysregulation of gene rearrangement in B cells.  815:423-426. 1997

Fat and energy balance.  827:431-448. 1997

Immunoglobulin J chain. An early differentiation marker of human B cells.  815:111-113. 1997

Inactivation of Th1 and Th2 cells by feeding ovalbumin.  778:122-132. 1996

Induction of tolerance in humans. Effectiveness of oral and nasal immunization routes.  778:194-201. 1996

Induction of tolerance in humans: Effectiveness of oral and nasal immunization routes.  778:194-201. 1996

Oral antigen delivery via a multiple emulsion system enhances oral tolerance.  778:156-62. 1996

Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance.  778:156-162. 1996

Role of γδ T cells in the regulation of mucosal IgA response and oral tolerance.  778:55-63. 1996

Somatostatin as a trophic factor: Analysis of transgenic mice overexpressing somatostatin in astrocytes.  780:29-35. 1996

Systemic and mucosal protective immunity to pneumococcal surface protein A.  797:118-126. 1996

The role of Th1 and Th2 cells for mucosal IgA responses.  778:64-71. 1996

A Complementary Method to Radioligand‐Mediated Autoradiography for Localizing Adrenergic, Alpha‐2 Receptor‐Producing Cells.  763:222-242. 1995

Analysis of DHQ52 Gene Segment Transcription and Rearrangement During B‐Cell Development in Human Fetal Bone Marrow.  764:228-230. 1995

Analysis of Immunoglobulin Gamma Heavy Chains from Rheumatoid Arthritis Synovium Evidence of Antigen‐Driven Selection.  764:450-460. 1995

Analysis of immunoglobulin gamma heavy chains from rheumatoid arthritis synovium.  764:450-452. 1995

Cord Blood Transplantation and the Potential for Gene Therapy: Gene Transduction Using a Recombinant Adeno‐Associated Viral Vector.  770:105-115. 1995

Development of the Mouse B‐Cell Repertoire.  764:207-221. 1995

Developmental Regulation of the Human Antibody Repertoire.  764:242-260. 1995

Effects of Okadaic Acid on Calcitriol‐and Phorbol Ester‐Induced Expression and Phosphorylation of Osteopontin in Mouse JB6 Epidermal Cells.  760:24-34. 1995

Human B‐Cell Development.  764:1-8. 1995

In Situ Hybridization Analysis of Immunoglobulin VH Gene Family Expression in Rheumatoid Arthritis.  764:453-456. 1995

Potentiation of B‐Cell Antigen Receptor‐mediated Signal Transduction by the Heterologous src Family Protein Tyrosine Kinase, src.  766:214-215. 1995

Structure—Function Studies of Human Monoclonal Antibodies to Pneumococcus Type 3 Polysaccharide.  764:370-373. 1995

T‐Cell Repertoires in Health and Disease.  756:53-65. 1995

Vβ17 T‐Cell Receptor Peptide Vaccine: Results of a Phase I Dose‐Finding Study in Patients with Rheumatoid Arthritis.  756:211-214. 1995

Cross‐Reactive Protection Eliciting Epitopes of Pneumococcal Surface Protein A.  730:361-363. 1994

Crystal Structure of T4 Endonuclease V: An Excision Repair Enzyme for a Pyrimidine Dimer.  726:198-207. 1994

Mouse Virulence Gene A (mviA⁺) Is a Pleiotropic Regulator of Gene Expression in Salmonella typhimurium.  730:295-296. 1994

Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems.  741:292-298. 1994

Application of X‐Ray Crystallographic Methods in the Design of Purine Nucleoside Phosphorylase Inhibitors.  685:237-247. 1993

Effects of Nonsteroidal Antiinflammatory Drugs on Bone Loss in Chronic Inflammatory Disease.  696:292-302. 1993

Electrophysiological Characteristics in Seronegative Myasthenia Gravis.  681:584-587. 1993

Saliva as a Manifestation of the Common Mucosal Immune System.  694:184-194. 1993

Effect of a VH81X‐Expressing IgM Antibody on Early B‐Cell Development.  651:160-161. 1992

Identification and Cloning of Rabbit CD5.  651:78-81. 1992

Idiotypic Regulation of Development of the B‐Cell Repertoire.  651:336-345. 1992

Opioid Modulation of Immunoglobulin Production by Lymphocytes Isolated from Peyer's Patches and Spleen.  650:125-127. 1992

Perinatally Derived Antiidiotypic Antibodies from the Antipolyfructosan Immune Response: Molecular Analysis of Idiotype Regulation.  651:316-318. 1992

The Fetal Omentum in Mice and Humans: A Site Enriched for Precursors of CD5 B Cells Early in Development.  651:10-20. 1992

Pro‐opiomelanocortin Expression and Potential Function of Pro‐opiomelanocortin Products during Induced Hair Growth in Mice.  642:459-461. 1991

Survey of Thymic Hormone Effects on Physical and Immunological Parameters in C57BL/6NNia Mice of Different Ages.  621:239-255. 1991

Autonomous Expression of the Differentiation Programs of Cells in the Cardiac and Skeletal Myogenic Lineages.  599:158-169. 1990

Bidirectional Communication between the Neuroendocrine and Immune Systems Common Hormones and Hormone Receptors.  579:17-27. 1990

Biochemical and Cellular Characteristics of Suppressin. A Novel Pituitary‐derived Inhibitor of Neuroendocrine and Immune Cell Proliferation.  594:393-395. 1990

Characteristics of Lymphocyte‐derived Proopiomelanocortin‐related mRNA.  594:382-384. 1990

Characterization of cDNA and Genomic Clones for the α Subunit of Human Prolyl 4‐Hydroxylase.  580:473-476. 1990

Corticotropin‐releasing Hormone Enhances Murine Natural Killer Cell Activity through an Opioid‐Mediated Pathway.  594:371-373. 1990

Detection of Transforming Growth Factor‐β2 and β3 Messenger Ribonucleic Acids in the Chicken.  593:313-313. 1990

Experimental Evidence for Autowaves in the Heart.  591:208-218. 1990

Growth Hormone Production and Growth Hormone Releasing Hormone Receptors in the Rat Immune System.  594:432-434. 1990

Mechanisms Underlying Ventricular Tachycardia and Fibrillation in the Ischemic Heart: Relation to Nonlinear Dynamics.  591:278-300. 1990

Novel Pharmacological Strategies in the Treatment of Life‐Threatening Cytomegalovirus Infections: Clinical Experience with Continuous Infusion 9‐(1,3‐Dihydroxy‐2‐Propoxymethyl) Guanine.  616:452-460. 1990

Use of ATP following Shock and Ischemia.  603:130-140. 1990

Chinese Hamster Ovary Cell Mutants Deficient in an Anion Exchanger Functionally Similar to Erythroid Band 3.  574:109-112. 1989

Differential Expression of Fv‐1 in Fibroblasts Derived from Embryonal Carcinoma Cells.  567:280-281. 1989

Immune Neuroendocrine Interactions: Implications for Reproductive Physiology.  564:261-266. 1989

Augmentation of Natural Immunity and Regulation of Tumor Growth by Conditioning.  521:29-42. 1988

Functional Analysis of Cd2, cd4, and cd8 in t‐Cell Activation.  532:199-206. 1988

Indirect Evidence of the Nature of the Antigen Receptor on Antigen‐Specific Suppressor Cells: Monoclonal Antibodies Against CAT‐Specific Suppressor Factors Can Alter the Capacity of H‐2 Specific Suppressor Cells to Regulate the Response of CTL to Allogeneic Target Cells.  546:204-206. 1988

Ketoconazole Treatment of Coccidioidal Meningitis.  544:488-496. 1988

Natural History and Pathogenesis of Neonatal Herpes Simplex Virus Infections.  549:103-117. 1988

Opioid Receptors on Murine Splenocytes: Possible Coupling to K+ Channels.  540:694-697. 1988

Opioid receptors on murine splenocytes. Possible coupling to K+ channels..  540:694-697. 1988

Rat Astrocyte Proliferation by Human B‐Cell Growth Factors.  540:392-395. 1988

Regulation of Self‐Tolerance to Insulin.  546:238-239. 1988

Significance of the Porosity and Physical Chemistry of Calcium Phosphate Ceramics: Orthopedic Uses.  523:278-282. 1988

A Possible Cause of Myasthenia Gravis: Idiotypic Networks Involving Bacterial Antigens.  505:461-471. 1987

Eight‐to‐Ten Percent Decremental Response is Not the Normal Limit For All Muscles.  505:851-853. 1987

Influence of Conditioned Natural Immunity on Tumor Growth.  496:637-646. 1987

Leukocyte Production of Endorphins.  496:192-195. 1987

Regulation of Natural Immunity (NK Activity) by Conditioning.  496:545-552. 1987

Bronchoalveolar Lavage Cell Analysis in Sarcoidosis: A Comparison of Lymphocyte Counts and Clinical Course.  465:678-684. 1986

Congenital Cytomegalovirus Infection: Prospects for Prevention.  477:123-127. 1986

Role of Microtubules in the Formation of Carotenoid Droplet Aggregate in Goldfish Xanthophores.  466:887-894. 1986

Studies of the Effects of Y Chromosome Factors on the Expression of Autoimmune Disease.  475:200-218. 1986

The Role of Sinoaortic and Cardiopulmonary Baroreceptor Reflex Arcs in Nociception and Stress‐Induced Analgesia.  467:385-401. 1986

Abnormal Accumulation of Basement Membrane (Type IV) and Cytoskeletal (Type V) Collagens in the Strictures of Crohn's Disease: The Probable Role of Intestinal Smooth Muscle Cells.  460:439-442. 1985

Biologic Regulation of Na/H Antiporter Activity in a Cultured Kidney Cell Line: Effects of Parathyroid Hormone (PTH).  456:451-453. 1985

Regulation of the Activity of the Na⁺‐H⁺ Antiporter in Brush‐Border Membrane Vesicles from the Proximal Tubule.  456:229-231. 1985

Small Proteins Affect Na⁺ Gradient‐Dependent d‐Glucose Transport in Isolated Renal Brush‐Border Membrane Vesicles.  456:101-104. 1985

ANTIBACTERIAL PROPERTIES OF MILK: IgA‐PEROXIDASE‐LACTOFERRIN INTERACTIONS.  409:848-850. 1983

AUGMENTATION OF IgA RESPONSES AND CARIES IMMUNITY BY ORAL ADJUVANTS.  409:851-852. 1983

Analysis of Idiotypic Heterogeneity in the Anti‐α1–3 Dextran and Anti‐Phosphorylcholine Responses Using Monoclonal Anti‐Idiotype Antibodies.  418:151-169. 1983

DEFICIENT IgA SYNTHESIS VIEWED IN THE CONTEXT OF NORMAL DEVELOPMENT OF IgA B‐CELLS.  409:461-468. 1983

DISTRIBUTION OF IgA1 AND IgA2 SUBCLASSES IN HUMAN TISSUE: CORRELATION WITH THE PRESENCE OF J‐CHAIN.  409:803-805. 1983

EFFECT OF DIMETHYL SULFOXIDE ON CHEMOTAXIS OF PHAGOCYTIC CELLS.  411:321-323. 1983

FUNCTION AND BIOSYNTHESIS OF POLYMERIC IgA.  409:292-306. 1983

Helper T cell activity in intestinal lamina propria.  409:230-230. 1983

IDENTIFICATION OF A NONADHERENT ACCESSORY CELL IN MURINE PEYER'S PATCHES.  409:880-881. 1983

IMMUNE REGULATION OF SUPPRESSION IN OFFSPRING OF ORALLY TOLERIZED MICE.  409:888-889. 1983

IgA HYBRIDOMAS TO CELL‐SURFACE COMPONENTS OF PATHOGENIC BACTERIA.  409:794-796. 1983

IgA RHEUMATOID FACTOR: EVIDENCE FOR INDEPENDENT EXPRESSION AT LOCAL SITES OF TISSUE INFLAMMATION.  409:258-272. 1983

IgA‐MEDIATED HEPATOBILIARY CLEARANCE OF BACTERIAL ANTIGENS.  409:871-872. 1983

MURINE PEYER'S PATCH T‐HELPER CELL CLONES THAT PREFERENTIALLY SUPPORT IgA RESPONSES.  409:829-830. 1983

PEYER'S PATCH ACCESSORY CELLS BEAR I‐A.  409:819-821. 1983

REGULATION OF IgA SUBCLASSES IN POKEWEED MITOGEN STIMULATED CULTURES.  409:797-798. 1983

SELECTIVE HEPATOBILIARY TRANSPORT OF MONOCLONAL IgG, BUT NOT IgM ANTI‐IDIOTYPIC ANTIBODIES, BY IgA.  409:859-860. 1983

THE IgA RESPONSE: INDUCTIVE ASPECTS, REGULATORY CELLS, AND EFFECTOR FUNCTIONS.  409:48-71. 1983

T‐HELPER CELL ACTIVITY IN INTESTINAL LAMINA PROPRIA.  409:230-237. 1983

Alzheimer's Disease, Down's Syndrome, and Aging: The Genetic Approach.  396:3-13. 1982

THE SELECTIVE ROLE OF MEMBRANE IgG IN THE ANTIGEN‐INDUCED INHIBITION OF HUMAN IN VITRO ANTIBODY PRODUCTION.  392:416-417. 1982

ACTION OF RETINOIDS AND PHORBOL ESTERS ON CELL GROWTH AND THE BINDING OF EPIDERMAL GROWTH FACTOR.  359:200-217. 1981

INTERACTION OF HUMAN ANTIBODY AND MURINE MONOCLONAL ANTIBODY WITH MUSCLE ACETYLCHOLINE RECEPTOR.  377:143-157. 1981

SPECIFIC AND NONSPECIFIC ALTERATIONS IN MEMBRANE MICROVISCOSITY INDUCED BY RETINOIDS IN EMBRYONAL CARCINOMA AND FIBROBLAST CELLS.  359:398-400. 1981

IMMUNE INTERFERON: SOME PROPERTIES AND FUNCTIONS.  350:130-144. 1980

ROLE OF MITOGENIC FACTOR, LYMPHOCYTE‐ACTIVATING FACTOR AND IMMUNE INTERFERON IN THE INDUCTION OF HUMORAL AND CELL‐MEDIATED IMMUNITY.  332:303-315. 1979

ROLE OF NONSPECIFIC AND SPECIFIC SUPPRESSOR FACTORS IN IMMUNITY.  332:336-344. 1979

ALERTNESS, LEVEL OF ACTIVITY, AND PURPOSIVE MOVEMENT FOLLOWING SOMATOSENSORY DEAFFERENTATION IN MONKEYS.  290:348-365. 1977